Neuro-oncology
- Temozolomide Bests Nivolumab in Glioblastoma With Unmethylated MGMT Promoter
- MRI Radiomics Prediction Model for Patients With Glioma Shows Stability
- Dabrafenib Plus Trametinib Effective for Gliomas With BRAF V600E Mutations
- Cabozantinib Shows Activity in RCC With Brain Metastases
- 2008 to 2017 Saw Decrease in Malignant Brain Tumor Incidence
- Predictive Models for Pediatric Neurofibromatosis Type 1
- Very Elderly Can Benefit From Brain Tumor Surgery
- Patients in Bind as Brain Cancer Drug Price Rises to $1,000 Per Pill
- Combination Immunotherapy for Melanoma and Asymptomatic Brain Metastases
- Occult Brain Metastasis Detected in Patients With Advanced Renal Cancer
- Risk Factors for Seizure Development in Patients with Brain Metastases
- Incidence of VTE, Major Bleeding High in Primary CNS Lymphoma
Conference Coverage
MORE MEETINGS
Clinical Tools
Powered by
Powered by 
MORE CLINICAL TOOLS
